Two Sigma Investments, LP Novo Nordisk A S Transaction History

Two Sigma Investments, LP

$42.8 Billion
Q1 2025

A detailed history of Two Sigma Investments, LP transactions in Novo Nordisk A S stock. As of the latest transaction made, Two Sigma Investments, LP holds 3,147,929 shares of NVO stock, worth $157 Million. This represents 0.51% of its overall portfolio holdings.

Number of Shares

3,147,929

Previous 1,844,423 70.67%

Holding current value

$157 Million

Previous $159 Million 37.78%

% of portfolio

0.51%

Previous 0.38%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	BUY	$69.3 - $90.95 $90.3 Million - $119 Million	1,303,506 Added 70.67%	3,147,929 $219 Million
Q4 2024 Feb 14, 2025	BUY	$85.0 - $120.04 $157 Million - $221 Million	1,844,423 New	1,844,423 $159 Million
Q4 2023 Feb 14, 2024	SELL	$87.78 - $105.45 $2,633 - $3,163	-30 Reduced 0.14%	21,600 $2.23 Million
Q3 2023 Nov 14, 2023	SELL	$90.94 - $199.54 $28.2 Million - $61.9 Million	-310,037 Reduced 93.48%	21,630 $1.97 Million
Q2 2023 Aug 14, 2023	BUY	$155.98 - $172.65 $47 Million - $52 Million	301,341 Added 993.67%	331,667 $53.7 Million
Q1 2023 May 15, 2023	BUY	$132.34 - $159.14 $2.82 Million - $3.39 Million	21,326 Added 236.96%	30,326 $4.83 Million
Q4 2022 Feb 14, 2023	BUY	$102.55 - $135.33 $922,950 - $1.22 Million	9,000 New	9,000 $1.22 Million
Q2 2022 Aug 15, 2022	BUY	$103.24 - $121.81 $2 Million - $2.36 Million	19,384 Added 17.82%	128,167 $14.3 Million
Q1 2022 May 16, 2022	SELL	$93.1 - $112.54 $21.1 Million - $25.5 Million	-226,782 Reduced 67.58%	108,783 $12.1 Million
Q4 2021 Feb 14, 2022	SELL	$95.88 - $117.08 $42.1 Million - $51.5 Million	-439,534 Reduced 56.71%	335,565 $37.6 Million
Q3 2021 Nov 15, 2021	BUY	$84.42 - $106.62 $26.6 Million - $33.6 Million	315,174 Added 68.53%	775,099 $74.4 Million
Q2 2021 Aug 16, 2021	BUY	$67.66 - $84.76 $668,886 - $837,937	9,886 Added 2.2%	459,925 $38.5 Million
Q1 2021 May 17, 2021	SELL	$67.06 - $75.82 $6.84 Million - $7.73 Million	-101,976 Reduced 18.47%	450,039 $30.3 Million
Q4 2020 Feb 16, 2021	BUY	$63.89 - $73.8 $4.6 Million - $5.32 Million	72,045 Added 15.01%	552,015 $38.6 Million
Q3 2020 Nov 16, 2020	SELL	$63.69 - $70.22 $13 Million - $14.3 Million	-203,525 Reduced 29.78%	479,970 $33.3 Million
Q2 2020 Aug 14, 2020	BUY	$58.54 - $67.94 $22 Million - $25.5 Million	375,001 Added 121.56%	683,495 $44.8 Million
Q1 2020 May 15, 2020	SELL	$49.46 - $64.78 $8.1 Million - $10.6 Million	-163,766 Reduced 34.68%	308,494 $18.6 Million
Q4 2019 Feb 14, 2020	BUY	$49.86 - $58.26 $2.32 Million - $2.71 Million	46,570 Added 10.94%	472,260 $27.3 Million
Q3 2019 Nov 14, 2019	BUY	$47.54 - $53.43 $14.8 Million - $16.6 Million	310,913 Added 270.88%	425,690 $22 Million
Q2 2019 Aug 14, 2019	SELL	$46.79 - $52.47 $10.3 Million - $11.6 Million	-220,867 Reduced 65.8%	114,777 $5.86 Million
Q1 2019 May 15, 2019	SELL	$46.36 - $52.63 $14.9 Million - $16.9 Million	-320,875 Reduced 48.88%	335,644 $17.6 Million
Q4 2018 Feb 14, 2019	BUY	$41.54 - $47.25 $154,030 - $175,203	3,708 Added 0.57%	656,519 $30.2 Million
Q3 2018 Nov 14, 2018	BUY	$46.76 - $51.24 $26.1 Million - $28.6 Million	558,230 Added 590.21%	652,811 $30.8 Million
Q2 2018 Aug 14, 2018	BUY	$44.29 - $50.42 $4.19 Million - $4.77 Million	94,581 New	94,581 $4.36 Million

Others Institutions Holding NVO

# of Institutions

1,748

Shares Held

332M

Call Options Held

10.5M

Put Options Held

16.2M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $112B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.

Account

Two Sigma Investments, LP Novo Nordisk A S Transaction History